Talk to the Veterans Crisis Line now
U.S. flag
An official website of the United States government

VA Health Systems Research

Go to the VA ORD website
Go to the QUERI website

HSR&D Citation Abstract

Search | Search by Center | Search by Source | Keywords in Title

Barriers to Adoption and Monitoring of Mineralocorticoid Receptor Antagonists in a VA Medical Center

Dev S, Hoffman T, Kavalieratos D, Schwenke D, Heidenreich P, Wu W, Tracy S. Barriers to Adoption and Monitoring of Mineralocorticoid Receptor Antagonists in a VA Medical Center. [Abstract]. Journal of the American College of Cardiology. 2015 Mar 1; 65(10_S):doi:10.1016/S0735-1097(15)60847-6.




Abstract:

Background: Poor adoption of mineralocorticoid receptor antagonist therapy (MRA) is a major gap in evidence-based care in the treatment of heart failure (HF). In order to improve care, the medical community needs a better understanding of the barriers experienced by providers. Methods: We conducted focus groups of providers (n = 42) from five populations: outpatient primary care, hospital medicine, cardiology, and pharmacy staff, and internal medicine residents. Focus groups entailed a mix of open-ended question and answer discussion, freewriting and brainstorming exercises, and polling. Focus group transcripts were analyzed with NVivo qualitative analysis software using iterative coding techniques that tagged between consideration of past research and emergent data. Results: Eight categories of barriers, centered at the provider, system, and patient levels, emerged as salient for understanding gaps in MRA prescription and monitoring (Table).





Questions about the HSR website? Email the Web Team

Any health information on this website is strictly for informational purposes and is not intended as medical advice. It should not be used to diagnose or treat any condition.